Physician
Psoriasis and Eczema Treatment Center of Western Michigan PLLC
Psoriasis and Eczema Treatment Center of Western Michigan PLLC was paid $2.36M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoPSORIASIS AND ECZEMA TREATMENT CENTER OF WESTERN MICHIGAN PLLC
GRAND RAPIDS, MI 49503
GRAND RAPIDS, MI 49503
33aNPI1396745055assigned 07/26/2005
33bProvider typeDermatology Physician
28Total paid$2.36M
24GClaims57,747
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in Michigan
Rank by total paid#6 of 51
Median peer was paid$67K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,534 | $234K | |
| 2019 | 7,352 | $314K | |
| 2020 | 6,730 | $287K | |
| 2021 | 9,371 | $444K | |
| 2022 | 16,532 | $414K | |
| 2023 | 7,088 | $369K | |
| 2024incomplete | 5,140 | $298K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 7,245 | 7,094 | $493K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 7,735 | 7,640 | $334K |
| 96910 | 13% | 4,904 | 1,062 | $301K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 12% | 6,938 | 6,899 | $274K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 4,083 | 4,083 | $248K |
| 11102 | 7.8% | 3,466 | 3,420 | $184K | |
| 17110 | 6.6% | 2,537 | 2,194 | $155K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.3% | 1,306 | 1,303 | $126K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 3,115 | 3,059 | $80K |
| 11103 | 2.1% | 931 | 913 | $49K | |
| 17000 | 1.4% | 1,152 | 1,143 | $32K | |
| 11100 | 1.1% | 491 | 472 | $25K |
20 more codes
| 11900 | 1.0% | 914 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,922 | $15K |
| 11901 | <1% | 278 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 157 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,965 | $3K |
| 17003 | <1% | 210 | $2K | |
| 17111 | <1% | 23 | $2K | |
| 11101 | <1% | 34 | $598.65 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $182.18 |
| G8482 | Influenza immunization administered or previously received | 0% | 585 | $0.00 |
| 4004F | 0% | 64 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 1,449 | $0.00 |
| G0030 | Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user | 0% | 520 | $0.00 |
| G9991 | Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period | 0% | 32 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,129 | $0.00 |
| G9989 | Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine) | 0% | 144 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 804 | $0.00 |
| 1036F | 0% | 2,556 | $0.00 | |
| G2181 | Bmi not documented due to medical reason or patient refusal of height or weight measurement | 0% | 27 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTAWISKI, MAREK (PHYSICIAN)